Zhang Y, Wu J, Dong E, Wang Z, Xiao H
Front Cardiovasc Med. 2023; 10:1143583.
PMID: 37113698
PMC: 10126280.
DOI: 10.3389/fcvm.2023.1143583.
Zhu K, Wang X, Weng Y, Mao G, Bao Y, Lou J
Cardiovasc Drugs Ther. 2022; 38(1):69-78.
PMID: 36194354
DOI: 10.1007/s10557-022-07383-3.
Ontoria-Oviedo I, Palacios I, Panadero J, Sanchez B, Garcia-Garcia F, Lopez-Cerdan A
Stem Cells Int. 2020; 2020:8872009.
PMID: 33101423
PMC: 7569451.
DOI: 10.1155/2020/8872009.
Zhang Y, Li Y, Huang X, Zhang F, Tang L, Xu S
Diabetes Ther. 2020; 11(5):1161-1173.
PMID: 32285313
PMC: 7193037.
DOI: 10.1007/s13300-020-00802-4.
Becher P, Hinrichs S, Fluschnik N, Hennigs J, Klingel K, Blankenberg S
PLoS One. 2018; 13(3):e0193844.
PMID: 29538462
PMC: 5851607.
DOI: 10.1371/journal.pone.0193844.
Toll Like Receptors Signaling Pathways as a Target for Therapeutic Interventions.
Jezierska A, Kolosova I, Verin A
Curr Signal Transduct Ther. 2017; 6(3):428-440.
PMID: 28373830
PMC: 5376075.
DOI: 10.2174/157436211797483930.
Tissue factor and Toll-like receptor (TLR)4 in hyperglycaemia-hyperinsulinaemia. Effects in healthy subjects, and type 1 and type 2 diabetes mellitus.
Singh A, Boden G, Rao A
Thromb Haemost. 2015; 113(4):750-8.
PMID: 25653143
PMC: 4677063.
DOI: 10.1160/TH14-10-0884.
Conditional knockout of prolyl hydroxylase domain protein 2 attenuates high fat-diet-induced cardiac dysfunction in mice.
Zeng H, Chen J
PLoS One. 2014; 9(12):e115974.
PMID: 25546437
PMC: 4278833.
DOI: 10.1371/journal.pone.0115974.
Activation of toll-like receptors and inflammasome complexes in the diabetic cardiomyopathy-associated inflammation.
Fuentes-Antras J, Ioan A, Tunon J, Egido J, Lorenzo O
Int J Endocrinol. 2014; 2014:847827.
PMID: 24744784
PMC: 3972909.
DOI: 10.1155/2014/847827.
How can we cure a heart "in flame"? A translational view on inflammation in heart failure.
Hofmann U, Frantz S
Basic Res Cardiol. 2013; 108(4):356.
PMID: 23740214
PMC: 3709073.
DOI: 10.1007/s00395-013-0356-y.
The immunopathology of sepsis: pathogen recognition, systemic inflammation, the compensatory anti-inflammatory response, and regulatory T cells.
Lewis D, Chan D, Pinheiro D, Armitage-Chan E, Garden O
J Vet Intern Med. 2012; 26(3):457-82.
PMID: 22428780
PMC: 7166777.
DOI: 10.1111/j.1939-1676.2012.00905.x.
MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction.
Singh M, Swaminathan P, Luczak E, Kutschke W, Weiss R, Anderson M
J Mol Cell Cardiol. 2012; 52(5):1135-44.
PMID: 22326848
PMC: 3327770.
DOI: 10.1016/j.yjmcc.2012.01.021.
Innate immune signaling in cardiac ischemia.
Arslan F, de Kleijn D, Pasterkamp G
Nat Rev Cardiol. 2011; 8(5):292-300.
PMID: 21448140
DOI: 10.1038/nrcardio.2011.38.
Prevention of hyperglycemia-induced myocardial apoptosis by gene silencing of Toll-like receptor-4.
Zhang Y, Peng T, Zhu H, Zheng X, Zhang X, Jiang N
J Transl Med. 2010; 8:133.
PMID: 21159162
PMC: 3020152.
DOI: 10.1186/1479-5876-8-133.
Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injury.
Abarbanell A, Wang Y, Herrmann J, Weil B, Poynter J, Manukyan M
Am J Physiol Heart Circ Physiol. 2010; 298(5):H1529-36.
PMID: 20173040
PMC: 2867442.
DOI: 10.1152/ajpheart.01087.2009.
Myocardial TLR4 is a determinant of neutrophil infiltration after global myocardial ischemia: mediating KC and MCP-1 expression induced by extracellular HSC70.
Ao L, Zou N, Cleveland Jr J, Fullerton D, Meng X
Am J Physiol Heart Circ Physiol. 2009; 297(1):H21-8.
PMID: 19448144
PMC: 2711729.
DOI: 10.1152/ajpheart.00292.2009.
Tissue factor and heart inflammation.
Pawlinski R, Mackman N
J Thromb Haemost. 2008; 7(2):288-9.
PMID: 19077112
PMC: 2834286.
DOI: 10.1111/j.1538-7836.2008.03257.x.
Post-infarct remodelling: contribution of wound healing and inflammation.
Frantz S, Bauersachs J, Ertl G
Cardiovasc Res. 2008; 81(3):474-81.
PMID: 18977766
PMC: 2639128.
DOI: 10.1093/cvr/cvn292.